Cargando…
Aberrant MicroRNAs in Pancreatic Cancer: Researches and Clinical Implications
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with a high rate of mortality and poor prognosis. Numerous studies have proved that microRNA (miRNA) may play a vital role in a wide range of malignancies, including PDAC, and dysregulated miRNAs, including circulating miRNAs, are a...
Autores principales: | Sun, Tao, Kong, Xiangyu, Du, Yiqi, Li, Zhaoshen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034662/ https://www.ncbi.nlm.nih.gov/pubmed/24899890 http://dx.doi.org/10.1155/2014/386561 |
Ejemplares similares
-
Rapid On-Site Evaluation Does Not Improve Endoscopic Ultrasound-Guided Fine Needle Aspiration Adequacy in Pancreatic Masses: A Meta-Analysis and Systematic Review
por: Kong, Fanyang, et al.
Publicado: (2016) -
MicroRNAs as potential therapeutic targets for pancreatic cancer
por: Chu, Xiangyu, et al.
Publicado: (2022) -
A prospective comparison of conventional cytology and digital image analysis for the identification of pancreatic malignancy in patients undergoing EUS-FNA
por: Kong, Fanyang, et al.
Publicado: (2019) -
MicroRNA-132 Plays an Independent Prognostic Role in Pancreatic Ductal Adenocarcinoma and Acts as a Tumor Suppressor
por: Chen, Yan, et al.
Publicado: (2019) -
Methylation of the SPARC gene promoter and its clinical implication in pancreatic cancer
por: Gao, Jun, et al.
Publicado: (2010)